Skip over main navigation
  • Log in
  • Basket: (0 items)
Haemochromatosis UK
Advice line Join us Donate
  • Twitter
Menu
  • About us
    • The genetics of haemochromatosis
    • Our team
    • Our charity
    • Our clinical advisors
    • Careers
    • Contact us
  • The difference we make
    • Research
    • APPG on GH
    • Videos
    • Our projects
      • Helplines
      • Venesection best practice
      • Travellers outreach
      • Community outreach
      • Expert patient
  • Get help
    • Common symptoms
    • Get tested for haemochromatosis
    • Newly diagnosed?
    • Contact our Nurse for advice
    • Information & advice
    • Treatment & care
    • Diet matters
    • Talking about GH
    • Can I donate blood?
    • Private venesections
    • FAQs
  • Healthcare professionals
    • Introduction to GH for Clinicians
    • Clinical guidelines
    • Clinician events
    • Primary care
      • Diagnosis & care
      • GP training
      • Pharmacy
    • Secondary care
      • Nursing
      • Arthropathy
      • Venesection Best Practice
    • Medical research grants
    • Clinic Packs
  • News and events
    • News
    • All Events
    • Iron Brews / Socials
    • Fundraising Events
    • Our blog
  • Get involved
    • Be a Member
    • Be a Friend
    • Be a Champion
    • Give money
      • Donate - Every little helps
      • Our appeals
      • A gift in your will
      • Online shopping partners
      • Pay In money you've raised
    • Give time, volunteer
      • Change the world
      • Current opportunities
    • Fundraise for us
      • Fundraising for us
      • Fundraising Events
      • Set up a fundraising page
      • Pay in money you've raised
    • Campaign with us
    • Shop
  • GH App
  • Admin
    • Log in
  • Basket: (0 items)
  • Genetics of haemochromatosis

Genetics of haemochromatosis

Inherited (genetic) disorders are caused by defective genes in the cells which make up the body.

Genes are made of DNA and contain the information the body needs to develop from the egg and to maintain itself in good working order. We have about 30,000 genes and every cell in the body, except sperm and egg cells, contains two copies of each. One of these copies is inherited from our mother and one from our father. In 1996 the HFE gene was identified as the major gene implicated in haemochromatosis.

Watch our short video on the genetics of haemochromatosis, hosted by our Registered Genetic Counsellor.

We have also produced a detailed guide to genetic haemochromatosis. This guide is included in our membership pack - join now! 

The genetics of GH

A small change (mutation) is present in both copies of the gene in over 90% of those diagnosed with GH. GH is an autosomal recessive disorder, which means that the risk of absorbing excess iron is higher if both copies of the gene are abnormal.

Someone with only one copy of a mutation rather than two is said to be a carrier. If only one copy is defective, an individual will usually be unaffected, but it is known that carriers. Some carriers are known to load iron, sometimes. A carrier is able to pass on his or her abnormal copy of the gene to a son or daughter.

Sperm and egg cells have only one copy of each gene, and on average half the eggs or half the sperm of a carrier will contain the defective version. By contrast, all the eggs or sperm of an individual in whom both gene copies are defective – and who, as a result, has haemochromatosis – will carry the abnormal gene.

To develop GH you have to inherit a defective gene or genes from your parents. This can happen in three ways.

1. If both parents are carriers

This is the most common situation. On average a quarter of resulting children will develop GH, half will be carriers, and a quarter will be unaffected (clear).

2. One parent has GH and the other is a carrier

This occurs in about 1 in 2000 partnerships. On average half of all children will develop GH, the other half will be carriers.

3. If both parents have GH

This is a rare event, occurring in about 1 in 100,000 partnerships. In this situation all children will definitely inherit two defective genes – one from each parent – and will therefore also have GH.

It should be emphasised that the proportions cited above are averages for the whole population. Thus, for example, in any particular family where both parents are carriers (scenario 1 above) it is possible for all children to be affected, all to be carriers, or for all to be clear.

How recessive inheritance works when both parents are carriers (scenario 1) is also shown in this diagram:

In the light of this relatives of someone who has been diagnosed and who are at risk should be tested. This is particularly important in the case of brothers and sisters (siblings) as they stand at least a 1 in 4 chance of being affected. Parents, partners and children, should also be tested.

The Celtic link

GH is sometimes described as The Celtic Curse. Although this is not a particularly attractive phrase, it does underscore the fact that those people with Celtic ancestry are far more likely to be affected.

Many people with GH can immediately identify Celtic family roots. However it is important to understand that the condition can affect people of all ethnicities, it is just more prevalent in people with Celtic roots.

Thus there are much higher rates of GH in Scotland, Northern Ireland (especially), the North-West of England, Republic of Ireland, Northern France and Northern Spain than elsewhere. The same applies to other parts of the world to where people from these areas subsequently migrated.

This map, from a 2016 study conducted in the US, shows the prevalence of genetic haemochromatosis across Europe. The dark red areas indicate high prevalence where relatively more people have the condition. The blue areas represent low prevalence.

Published: 14th January, 2020

Updated: 10th February, 2023

Author: Phil Treble

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • The Great North Run 2024

    The Great North Run 2024

    The AJ Bell Great North Run is the world’s biggest and best half marathon, with 60,000 runners taking on the route from Newcastle to South Shields each year. We hope to have places announced soon!

  • Jam-packed clinical event season

    Jam-packed clinical event season

    November was a hectic month for clinician events, with conferences in London, Manchester & Liverpool.

  • Nursing Live '24

    Nursing Live '24

    Meet #TeamIronOverload at Nursing Live in Liverpool.

  • Northern Ireland Awareness Campaign Kicks Off

    Northern Ireland Awareness Campaign Kicks Off

    This month, we're launching a multi-channel TV, press, billboard and radio campaign to raise awareness of genetic haemochromatosis across Northern Ireland.

Related

  • GH : A Guide for Employers

    GH : A Guide for Employers

    This guide, produced by the employment law team at Gowling WLG (UK) LLP, provides advice to employers whose staff have genetic haemochromatosis.

  • Juvenile (type 2) genetic haemochromatosis

    Juvenile (type 2) genetic haemochromatosis

    This guide for parents and carers explains the rare type 2 variant of genetic haemochromatosis, which typically affects young people under 25 years old.

  • Diabetes and genetic haemochromatosis

    Diabetes and genetic haemochromatosis

    "I’ve got diabetes and haemochromatosis - what does this mean for me?"

  • The effects of genetic haemochromatosis screening on screening participants

    The effects of genetic haemochromatosis screening on screening participants

    This study, undertaken 2022, demonstrates that screening for genetic haemochromatosis neither attracts the worried well nor causes anxiety.

  • An analysis of genetic haemochromatosis treatment approaches across the UK

    An analysis of genetic haemochromatosis treatment approaches across the UK

    In this report, we discuss the results of a survey on genetic haemochromatosis treatment approaches in the UK.

  • The effects of genetic haemochromatosis on mental health: a post COVID-19 pandemic study

    The effects of genetic haemochromatosis on mental health: a post COVID-19 pandemic study

    This study, published in November 2022, reveals that people with genetic haemochromatosis are at greater risk of suffering with poor mental health than the general population.

  • GH & Your Employment Rights

    GH & Your Employment Rights

    This essential guide, produced by the employment law team at Gowling WLG (UK) LLP, explains your employment rights if you have genetic haemochromatosis.

  • Vitamins during treatment

    Vitamins during treatment

    It’s possible to develop vitamin deficiency whilst undergoing venesection treatment for genetic haemochromatosis. Our leaflet explains more.

  • Evaluating the Cost of Illness of Genetic Haemochromatosis in the UK

    Evaluating the Cost of Illness of Genetic Haemochromatosis in the UK

    Our latest report reveals the true costs to the NHS of the burden of ill-health arising from genetic haemochromatosis.

  • Pregnancy and Genetic Haemochromatosis

    Pregnancy and Genetic Haemochromatosis

    A guide for prospective parents who have genetic haemochromatosis and intend to become, or are currently, pregnant.

Most read

  • What is genetic haemochromatosis?

    What is genetic haemochromatosis?

    Genetic haemochromatosis (GH) is a genetic disorder causing the body to absorb an excessive amount of iron from the diet.

  • Genetic Testing for Haemochromatosis

    Genetic Testing for Haemochromatosis

    Our genetic testing service for haemochromatosis, at a glance. Order a home-testing kit by post, get the results within 2 weeks.

  • Breakfast Cereals and their Iron Content

    A rough guide to the Iron content in cereals

  • Treatment & care

  • Employers' guide to haemochromatosis

    Employers' guide to haemochromatosis

    People with genetic haemochromatosis want to play an active role in society. These guidelines are intended to help employers understand how they can help people with genetic haemochromatosis in the workplace.

  • Clinical Guidelines for Genetic Haemochromatosis

    Our charity endorses the national clinical guidelines published by the British Society for Haematology in April 2018, for the treatment of people with genetic haemochromatosis. We strongly encourage patients to ensure that their consultants and venesection teams work to the BSH April 2018 guidelines.

  • CV19 Vaccine & Haemochromatosis

    CV19 Vaccine & Haemochromatosis

    Advice and information on the new Covid-19 vaccines for people affected by genetic haemochromatosis. Updated 14th June 2021.

  • Genetics of haemochromatosis

    Genetics of haemochromatosis

    Genetic haemochromatosis is an autosomal recessive condition, meaning that it is inherited. Whether someone inherits the condition, depends upon their parents' genetics.

  • Advice lines

    Advice lines

    Our advice lines are available by phone and email. Worried about genetic haemochromatosis? Don't be. Talk to us for friendly, practical help & understanding.

  • Join us

    Together, we are stronger. Join today as a member and receive the many benefits of membership of the UK's only charity for people affected by genetic haemochromatosis.

Tag cloud

In Memory

Sign up for our monthly newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])
  • Contact us
  • FAQs
  • Our Policies
  • Privacy Policy
  • Accessibility
  • Sitemap
  • Twitter
  • Facebook
  • YouTube

Registered office: The Flaxmill, Flaxmill Lane, Pinchbeck, Spalding PE11 3YP.
Phone: 03030 401 101 / Email: [email protected] / Open: Mon–Fri 9am–3pm

Registered as Charity number 1001307 and SCO41701. Company Limited by Guarantee No. 2541361.
Copyright © 2023 Haemochromatosis UK. All Rights Reserved.

© 2023 Haemochromatosis UK

Manage Cookie Preferences